Harry Bleiberg
Impact in
- Oncology top 0.2%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Colorectal Cancer Surgical Treatments
- HER2/EGFR in Cancer Research
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 89
- Colorectal Cancer Treatments and Studies 61
- Cancer Treatment and Pharmacology 23
-
- Gastric Cancer Management and Outcomes 38
- Co-authors
- Eric Van Cutsem (11 shared papers)David Cunningham (3 shared papers)Yves Humblet (5 shared papers)David Khayat (2 shared papers)M. Mueser (1 shared paper)Ian Chau (1 shared paper)A. Harstrick (1 shared paper)Armando Santoro (1 shared paper)
- Journals
- European Journal of Cancer (19 papers)Journal of Clinical Oncology (17 papers)Annals of Oncology (11 papers)Anti-Cancer Drugs (7 papers)British Journal of Cancer (7 papers)
- Partner nations
- BelgiumFranceNetherlands
In The Last Decade
Harry Bleiberg
159 papers receiving 9.7k citations
Harry Bleiberg's Hit Papers
Peers
Comparison fields: 5 of 129
- Oncology 5.7k
- Hepatology 1.2k
- Pulmonary and Respiratory Medicine 3.0k
- Gastroenterology 299
- Pathology and Forensic Medicine 973
Countries citing papers authored by Harry Bleiberg
This map shows the geographic impact of Harry Bleiberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry Bleiberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry Bleiberg more than expected).
Fields of papers citing papers by Harry Bleiberg
This network shows the impact of papers produced by Harry Bleiberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry Bleiberg. The network helps show where Harry Bleiberg may publish in the future.
Co-authors
The 25 scholars most cited alongside Harry Bleiberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 162 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer Hit paper breakdown → | 2004 | 3873 |
| 2 | Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer Hit paper breakdown → | 1998 | 788 |
| 3 | 2000 | 441 | |
| 4 | 2008 | 408 | |
| 5 | 2006 | 345 | |
| 6 | 1991 | 310 | |
| 7 | 1997 | 236 | |
| 8 | 2015 | 177 | |
| 9 | 2000 | 155 | |
| 10 | 2007 | 128 | |
| 11 | 2013 | 118 | |
| 12 | 1998 | 103 | |
| 13 | 1999 | 98 | |
| 14 | Natural history of the colorectal cancer. | 1993 | 96 |
| 15 | Cell renewal in the human rectum. In vitro autoradiographic study on active ulcerative colitis. | 1970 | 96 |
| 16 | 2002 | 91 | |
| 17 | 1996 | 88 | |
| 18 | 1999 | 85 | |
| 19 | 1985 | 84 | |
| 20 | 1986 | 83 |
About Harry Bleiberg
Harry Bleiberg is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Pathology and Forensic Medicine and Hepatology, having authored 162 papers that have together received 10.1k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (61 papers), Gastric Cancer Management and Outcomes (38 papers), Cancer Treatment and Pharmacology (23 papers), Hepatocellular Carcinoma Treatment and Prognosis (20 papers), Genetic factors in colorectal cancer (20 papers), Nausea and vomiting management (19 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers) and Chemotherapy-induced organ toxicity mitigation (10 papers). The work is most often cited by research in Oncology (5.7k citations), Hepatology (1.2k citations), Pulmonary and Respiratory Medicine (3.0k citations), Gastroenterology (299 citations) and Pathology and Forensic Medicine (973 citations). Harry Bleiberg has collaborated with scholars based in Belgium, France and Netherlands. Frequent co-authors include Eric Van Cutsem, David Cunningham, Yves Humblet, David Khayat, M. Mueser, Ian Chau, A. Harstrick, Armando Santoro, Chris Verslype and Salvatore Siena. Their work appears in journals such as European Journal of Cancer, Journal of Clinical Oncology, Annals of Oncology, Anti-Cancer Drugs and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.